(Q46464196)

English

Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.

scientific article published on 12 February 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

Konrad Szosland

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Andrzej Lewiński

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Krzysztof C Lewandowski

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Chris O'Callaghan

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Bee K Tan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Harpal S Randeva

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

12 February 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

85

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

61-69

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Low resistin levels in adipose tissues and serum in high-fat fed mice and genetically obese mice: development of an ELISA system for quantification of resistin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Increased Resistin Gene and Protein Expression in Human Abdominal Adipose Tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Cardiovascular risk in women with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Mortality of women with polycystic ovary syndrome at long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Serum adiponectin levels in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Adiponectin levels in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Serum resistin levels in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

The assessment of insulin resistance in man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Repeatability characteristics of simple indices of insulin resistance: implications for research applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Diagnosis and complications of Cushing's syndrome: a consensus statement.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Insulin resistance in obesity: metabolic mechanisms and measurement methods.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Plasma adiponectin increases postprandially in obese, but not in lean, subjects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

The postprandial response of adiponectin to a high-fat meal in normal and insulin-resistant subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Obesity, adiponectin and vascular inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Association between adiponectin and mediators of inflammation in obese women.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Adiponectin stimulates production of nitric oxide in vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

An inflammatory cascade leading to hyperresistinemia in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.12.014

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMGME.2004.12.014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

release_zfx4bva7tbfiri2f47h46lijvy

1 reference

https://api.fatcat.wiki/v0/release/zfx4bva7tbfiri2f47h46lijvy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15862282%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46464196&oldid=2137084258"